NK510 Cell Therapy

NK510 · Base Therapeutics (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NK510 Cell Therapy, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus [NA]